Breast cancer doesn't affect sexual function in women

July 26, 2012
Breast cancer doesn't affect sexual function in women
Sexual function does not seem to be significantly disrupted in women with a diagnosis of ductal carcinoma in situ, according to a study published online July 19 in The Journal of Sexual Medicine.

(HealthDay) -- Sexual function does not seem to be significantly disrupted in women with a diagnosis of ductal carcinoma in situ (DCIS), according to a study published online July 19 in The Journal of Sexual Medicine.

Sharon L. Bober, Ph.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues assessed self-reported measures of psychosexual functioning and body image in 304 sexually active women diagnosed with DCIS within the previous three months. Outcomes were assessed at baseline and at nine and 18 months.

The researchers found that was very similar in women with DCIS and women in the general population, with no significant disruption noted for women with a diagnosis of DCIS. Over 18 months of follow-up, sexual function and body image were notably stable. There were no differences in for patients who had reconstruction compared with patients who did not have reconstruction following mastectomy.

"Although it has been shown that women with DCIS face a number of significant psychosocial challenges, including vulnerability to anxiety, depression, and heightened inaccurate risk perceptions, it is positive news that sexual function may not be significantly negatively affected by this diagnosis," the authors write. "Moreover, it is noteworthy that these findings held true for women who underwent mastectomy as well as hormonal therapy."

Explore further: Diagnostic and invasive procedures common in women with breast-conserving surgery

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Diagnostic and invasive procedures common in women with breast-conserving surgery

April 5, 2012
Women with ductal carcinoma in situ (DCIS) have high rates of diagnostic and invasive breast procedures after treatment with breast-conserving surgery (BCS) according to a study published April 5 in the Journal of the National ...

Vaginal dilation outcomes equivalent to vaginoplasty

July 13, 2012
(HealthDay) -- Long-term psychosexual outcomes for patients undergoing vaginal dilation are at least equivalent to those undergoing vaginoplasty, according to a study published in the July issue of The Journal of Sexual Medicine.

Transvaginal mesh op restores pelvic organ prolapse at price

May 26, 2012
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to a study published ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.